SCHEMBL16865356

SCHEMBL16865356

CCOC(=O)CC(=O)/C=C/Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.48
MAPT P10636 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.42
TSHR P16473 1/20 0.42
F13A1 P00488 1/20 0.42
TGM2 P21980 1/20 0.42
TGM1 P22735 1/20 0.42
MMP8 P22894 2/20 0.41
GSK3B P49841 1/20 0.41
BACE1 P56817 1/20 0.41
LTA4H P09960 2/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MAOB P27338 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11974561 0.83 MAOB (0.58) MAPTMEN1KMT2AGSK3BBACE1
SCHEMBL6263496 0.81 MAPT (0.57) MAPTF13A1TGM2TGM1MAOB
SCHEMBL6263498 0.81 MAPT (0.57) MAPTF13A1TGM2TGM1MAOB
SCHEMBL3105202 0.80 HAO1 (0.62) MAPTMEN1KMT2ASMN1; SMN2GSK3B
SCHEMBL3105207 0.80 HAO1 (0.62) MAPTMEN1KMT2ASMN1; SMN2GSK3B
SCHEMBL27344990 0.80 MAOB (0.50) PPIDMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL23189167 0.77 MEN1 (0.49) MAPTMEN1KMT2ASMN1; SMN2F13A1
SCHEMBL9796725 0.77 PPID (0.46) PPIDMEN1KMT2ASMN1; SMN2TSHR
SCHEMBL9796731 0.77 PPID (0.46) PPIDMEN1KMT2ASMN1; SMN2TSHR
SCHEMBL27087386 0.76 ABCB1 (0.45) PPIDMAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133488-B2 Synthetic methods and compounds related thereto UNIVERSITY OF ALASKA FAIRBANKS (US) 2015-09-15 US disclosed
US-9133488-B2 Synthetic methods and compounds related thereto UNIVERSITY OF ALASKA FAIRBANKS (US) 2015-09-15 US disclosed
US-20150184206-A1 SYNTHETIC METHODS AND COMPOUNDS RELATED THERETO UNIVERSITY OF ALASKA FAIRBANKS 2015-07-02 US disclosed
US-20150184206-A1 SYNTHETIC METHODS AND COMPOUNDS RELATED THERETO UNIVERSITY OF ALASKA FAIRBANKS 2015-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150184206-A1 SYNTHETIC METHODS AND COMPOUNDS RELATED THERETO LSS, CYP51A1, FASN PPID 720/4885MAPT 3810/4885MEN1 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.